A j/v with a Co that has a good development/operational track record would be a good way to go. As you say that will leave the team free to do what they do best
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025